To study the possible correlation between the bioactivity ratios of the serum TSH and serum thyroid hormone concentrations in patients with primary hypothyroidism, the bioactivity of TSH in these patients was determined by means of a sensitive and practical bioassay and the results were compared to those in normal subjects.
The serum thyrotropin (TSH) concentration has generally been determined by radioimmunoassay, which does not necessarily reflect the bioactivity. Although cytochemical bioassay is sufficiently sensitive to measure a normal or even suppressed amount of TSH in serum (Bitensky et al., 1974) , this procedure is rather difficult to perform and the equipment required for the assay is available only in a limited number of laboratories. Dahlberg et al. (1987) developed a bioassay for TSH, in which they employed the immunoaffinity chromatography extraction method and FRTL-5 rat thyroid cells. They found an inverse correlation between the bioactivity-to-immunoreactivity ratios of serum TSH and serum thyroid hormone concentrations in normal subjects and in patients with primary hypothyroidism . On the other hand, Tokuda et al.(1988) demonstrated a constant bioactivity-to-immunoreactivity ratio in patients with various degrees of primary hypothyroidism, as measured by a new bioassay in which they employed anti-TSH magnetizable solid-phase-bound polyclonal antibodies.
Therefore, there is still controversy concerning changes in the bioactivity of TSH in patients with primary hypothyroidism.
Recently, we also developed a sensitive and practical bioassay for human serum TSH (Horimoto et al., 1989) . In the present study, we determined the bioactivity of serum TSH in patients with primary hypothyroidism, and compared the results with those in normal subjects. amounts of extracts from TSH free serum or lyophilized dialyzates were added. There was thus no significant difference in the amount of cAMP, indicating the validity of the dilution with the TSH free serum. Serial dilutions of the sera from normal subjects with the TSH free serum yielded curves which were perallel to the standard curve (Figure 1) . A linear relation was found between serum TSH, measured by the immunoassay, and the bioactivity of the TSH, measured by the present assay, in normal subjects (y=1.13x-0.3, r=0.89, p<0.01)( Figure  2A ). Similarly, a direct relation between the serum TSH concentration and the bioactivity was evident in patients with primary hypothyroidism (y=0.90 x+0.7, r= 0.93, p<0.01) ( Figure 2B ). The regression line in patients with primary hypothyroidism was not significantly different from that in normal subjects based on analysis of covariance. (Horimoto et al., 1989) . Therefore, an advantage of the present method is that the extraction is sensitive and specific for human TSH, in addition to the facility of the procedure. Of special interest were the possible differences between the biological activity and the immunological activity of TSH in normal subjects and in patients with primary hypothyroidism. Dahlberg et al.,(1987) and Nissim et al.,(1987) suggested that there was an inverse correlation between the serum thyroid hormone concentration and the bioactivity-to-immunoreactivity ratio of immunopurified basal TSH in normal subjects and in patients with primary hypothyroidism. In contrast, in the present study, the regression line between the bioactivity and the immunoreactivity of TSH in patients with primary hypothyroidism was almost identical to that in normal subjects. The discrepancy between the previous results ) and the present re-BIOASSAY, BIOACTIVITY, HYPOTHYROIDISM sults could be attributable at least in part to the difference in the extraction procedure. In the previous study , up to 400 times purification of serum TSH was achieved according to the serum TSH concentration, so that non-TSH stimulator(s) or inhibitor(s) in the serum might also be concentrated by their method. On the other hand, serum from patients with primary hypothyroidism was diluted with TSH free serum in the present method, but the addition of extract from TSH free serum did not affect the results of our bioassay. Dilution of the sample serum with the TSH free serum was therefore considered not to influence the measurement by the present assay. Tokuda et al.(1988) demonstrated a constant bioactivity-to-immunoreactivity ratio in patients with various degrees of primay hypothyroidism as determined by a bioassay with a magnetizable solid-phasebound polyclonal antibody. Although the bioactivity-to-immunoreactivity ratios in normal subjects could not been determined by their method, the findings in patients with primary hypothyroidism were consistent with the present results.
The and-TSH monoclonal antibody, which might recognize only parts of TSH, was employd in this extraction method. However, immunoreactive-recovery rates of the extracts measured with the and-TSH polyclonal antibody were constant in normal subjects and in patients with primary hypothyroidism, and the mean recovery rate in the patients was not different from that in the normal subjects, suggesting that the TSH which was extracted with the and-TSH monoclonal antibody reflects the whole TSH which was determined with the and-TSH polyclonal antibody.
In conclusion, the bioactivity of TSH, as determined by the present assay, was parallel to the immunoreactivity of TSH in normal subjects and in patients with primary hypothyroidism, and the bioactivityto-immunoreactivity ratio in patients with primary hypothyroidism is thought to be identical to that in normal subjects.
